Cat. No. 2710
Chemical Name: 2-[4-[[3-(4-Bromophenyl)-1-oxo-2-pr
Biological ActivityHeparanase inhibitor (IC50 = 0.4 μM) that displays no major inhibition of human cytochrome P450 isoenzymes (IC50 > 30 μM). Exhibits antiangiogenic properties in vitro (IC50 = 1 μM).
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Certificate of Analysis / Product Datasheet / Safety Datasheet
References are publications that support the products' biological activity.
McKenzie (2007) Heparanase: a target for drug discovery in cancer and inflammation. Br.J.Pharmacol. 151 1. PMID: 17339837.
Courtney et al (2005) Furanyl-1,3-thiazol-2-yl and benzoxazol-5-yl acetic acid derivates: novel classes of heparanase inhibitor. Bioorg.Med.Chem.Letts. 15 2295.
If you know of a relevant reference for OGT 2115 please let us know.
Citations are publications that use Tocris products.
Do you know of a great paper that uses OGT 2115 from Tocris? If so please let us know.
View Related Products by Target
View Related Products by Product Action
Keywords: OGT 2115, supplier, Antiangiogenic, Heparanase, inhibitors, inhibits, Antiangiogenics, Glycosylases, Carbohydrate, Metabolism, OGT2115, Tocris Bioscience, Antiangiogenic products